Literature DB >> 21399729

Defining mild cognitive impairment: impact of varying decision criteria on neuropsychological diagnostic frequencies and correlates.

John A Schinka1, David A Loewenstein, Ashok Raj, Mike R Schoenberg, Jessica L Banko, Huntington Potter, Ranjan Duara.   

Abstract

OBJECTIVE: To examine the impact of varying decision criteria on neuropsychological diagnostic frequencies and on their correlates.
DESIGN: Descriptive and correlational study.
SETTING: Florida Alzheimer's Disease Research Center. PARTICIPANTS: A sample of 373 individuals with comprehensive baseline analyses participating in a longitudinal study of cognitive decline and early Alzheimer disease. MEASUREMENTS: Mild cognitive impairment (MCI) diagnoses were made on the basis of four sets of decision criteria created by crossing two approaches: varying the number of impaired test results required for a diagnosis within any domain (1 test versus 2) and varying the performance level required to determine impairment (1.5 or 2 standard deviations [SDs] below the normative mean) for any test.
RESULTS: Under each criteria set, single-domain amnestic MCI was the most frequent MCI diagnosis. MCI global and subtype diagnosis frequencies were inversely related to the stringency of the criteria. The single test-1.5 SD criterion identified the largest number of cases as qualifying for an MCI diagnosis, and the two test-2.0 SD cutoff identified the fewest. Across all sets of criteria, the authors found significant positive associations between neuropsychological diagnoses and Clinical Dementia Rating score categories. Significant relationships between diagnoses and both apolipoprotein E (APOE) genotype and magnetic resonance imaging ratings of medial temporal atrophy (MTA) application were found only for the two test-1.5 SD and two test-2.0 SD cutoffs.
CONCLUSION: MCI diagnosis frequencies are substantively affected by the stringency of the criteria, but the relative rankings of MCI subtype diagnoses are fairly consistent regardless of the stringency of the criteria. Significant associations of neuropsychological diagnoses with independent markers such as APOE genotype and MTA are only found with more stringent criteria, suggesting that a coherent network of associations reflecting cognitive decline occurs with more restrictive definitions for impairment.

Entities:  

Keywords:  Alzheimer’s disease; Mild cognitive impairment; aging; cognition; neuropsychological tests

Mesh:

Substances:

Year:  2010        PMID: 21399729      PMCID: PMC3052876          DOI: 10.1097/JGP.0b013e3181e56d5a

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  28 in total

1.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.

Authors:  C R Jack; R C Petersen; Y C Xu; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; S C Waring; E G Tangalos; E Kokmen
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

2.  Apolipoprotein E genotyping by one-stage PCR.

Authors:  P R Wenham; W H Price; G Blandell
Journal:  Lancet       Date:  1991-05-11       Impact factor: 79.321

3.  Mayo's older Americans normative studies: category fluency norms.

Authors:  J A Lucas; R J Ivnik; G E Smith; D L Bohac; E G Tangalos; N R Graff-Radford; R C Petersen
Journal:  J Clin Exp Neuropsychol       Date:  1998-04       Impact factor: 2.475

Review 4.  Current epidemiology of mild cognitive impairment and other predementia syndromes.

Authors:  Francesco Panza; Alessia D'Introno; Anna Maria Colacicco; Cristiano Capurso; Angelo Del Parigi; Richard J Caselli; Alberto Pilotto; Giovanni Argentieri; Pier Luigi Scapicchio; Emanuele Scafato; Antonio Capurso; Vincenzo Solfrizzi
Journal:  Am J Geriatr Psychiatry       Date:  2005-08       Impact factor: 4.105

5.  Conversion from subtypes of mild cognitive impairment to Alzheimer dementia.

Authors:  P Fischer; S Jungwirth; S Zehetmayer; S Weissgram; S Hoenigschnabl; E Gelpi; W Krampla; K H Tragl
Journal:  Neurology       Date:  2007-01-23       Impact factor: 9.910

6.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

7.  Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies.

Authors:  A J Mitchell; M Shiri-Feshki
Journal:  Acta Psychiatr Scand       Date:  2008-02-18       Impact factor: 6.392

8.  Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.

Authors:  Shannon L Risacher; Andrew J Saykin; John D West; Li Shen; Hiram A Firpi; Brenna C McDonald
Journal:  Curr Alzheimer Res       Date:  2009-08       Impact factor: 3.498

9.  Potential for misclassification of mild cognitive impairment: a study of memory scores on the Wechsler Memory Scale-III in healthy older adults.

Authors:  Brian L Brooks; Grant L Iverson; James A Holdnack; Howard H Feldman
Journal:  J Int Neuropsychol Soc       Date:  2008-05       Impact factor: 2.892

10.  Stability of different subtypes of mild cognitive impairment among the elderly over a 2- to 3-year follow-up period.

Authors:  David A Loewenstein; Amarilis Acevedo; Brent J Small; Joscelyn Agron; Elizabeth Crocco; Ranjan Duara
Journal:  Dement Geriatr Cogn Disord       Date:  2009-04-09       Impact factor: 2.959

View more
  29 in total

Review 1.  Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.

Authors:  Irene Litvan; Jennifer G Goldman; Alexander I Tröster; Ben A Schmand; Daniel Weintraub; Ronald C Petersen; Brit Mollenhauer; Charles H Adler; Karen Marder; Caroline H Williams-Gray; Dag Aarsland; Jaime Kulisevsky; Maria C Rodriguez-Oroz; David J Burn; Roger A Barker; Murat Emre
Journal:  Mov Disord       Date:  2012-01-24       Impact factor: 10.338

2.  Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.

Authors:  Jennifer G Goldman; Samantha Holden; Bryan Bernard; Bichun Ouyang; Christopher G Goetz; Glenn T Stebbins
Journal:  Mov Disord       Date:  2013-10-09       Impact factor: 10.338

3.  Normative and standardized data for cognitive measures in the Mexican Health and Aging Study.

Authors:  Silvia Mejía-Arango; Rebeca Wong; Alejandra Michaels-Obregón
Journal:  Salud Publica Mex       Date:  2015

4.  Understanding white matter structural connectivity differences between cognitively impaired and nonimpaired active professional fighters.

Authors:  Virendra R Mishra; Karthik R Sreenivasan; Xiaowei Zhuang; Zhengshi Yang; Dietmar Cordes; Sarah J Banks; Charles Bernick
Journal:  Hum Brain Mapp       Date:  2019-08-12       Impact factor: 5.038

5.  Diastolic Blood Pressure, Not Just Systolic Blood Pressure, Is Related to Cerebral Measures in Middle Age: Implications for Prospective Studies.

Authors:  Merrill F Elias; Rachael V Torres; Adam Davey
Journal:  Am J Hypertens       Date:  2018-11-13       Impact factor: 2.689

6.  PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS).

Authors:  Matthew T Mefford; Robert S Rosenson; Mary Cushman; Michael E Farkouh; Leslie A McClure; Virginia G Wadley; Marguerite R Irvin; Vera Bittner; Monika M Safford; Ransi Somaratne; Keri L Monda; Paul Muntner; Emily B Levitan
Journal:  Circulation       Date:  2017-11-16       Impact factor: 29.690

7.  Pattern of cognitive impairment in older veterans with posttraumatic stress disorder evaluated at a memory disorders clinic.

Authors:  R Scott Mackin; Julia A Lesselyong; Kristine Yaffe
Journal:  Int J Geriatr Psychiatry       Date:  2011-12-23       Impact factor: 3.485

8.  Validation of the Spanish Version of the LASSI-L for Diagnosing Mild Cognitive Impairment and Alzheimer's Disease.

Authors:  Jordi A Matías-Guiu; Rosie E Curiel; Teresa Rognoni; María Valles-Salgado; Marta Fernández-Matarrubia; Roshan Hariramani; Alejandro Fernández-Castro; Teresa Moreno-Ramos; David A Loewenstein; Jorge Matías-Guiu
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

9.  The diagnostic value of controlled oral word association test-FAS and category fluency in single-domain amnestic mild cognitive impairment.

Authors:  Michael Malek-Ahmadi; Brent J Small; Ashok Raj
Journal:  Dement Geriatr Cogn Disord       Date:  2011-12-08       Impact factor: 2.959

10.  Low 25-Hydroxyvitamin D Concentrations and Risk of Incident Cognitive Impairment in Black and White Older Adults: The Health ABC Study.

Authors:  Laurel Kilpatrick; Denise K Houston; Valerie K Wilson; James Lovato; Hilsa N Ayonayon; Jane A Cauley; Tamara Harris; Eleanor M Simonsick; Kristine Yaffe; Stephen B Kritchevsky; Kaycee M Sink
Journal:  J Nutr Gerontol Geriatr       Date:  2018-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.